Free Trial
LON:HEMO

Hemogenyx Pharmaceuticals (HEMO) Share Price, News & Analysis

Hemogenyx Pharmaceuticals logo
GBX 141.88 -3.12 (-2.15%)
As of 06:42 AM Eastern

About Hemogenyx Pharmaceuticals Stock (LON:HEMO)

Key Stats

Today's Range
137.28
152
50-Day Range
145.96
186.81
52-Week Range
137.28
1,200
Volume
23,826 shs
Average Volume
31,222 shs
Market Capitalization
£5.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

HEMO Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Hemogenyx Pharmaceuticals Announces Key Corporate Changes
See More Headlines

HEMO Stock Analysis - Frequently Asked Questions

Hemogenyx Pharmaceuticals' stock was trading at GBX 402 at the beginning of the year. Since then, HEMO stock has decreased by 64.7% and is now trading at GBX 141.88.

Hemogenyx Pharmaceuticals Plc (LON:HEMO) posted its quarterly earnings data on Monday, April, 28th. The company reported ($181.10) earnings per share for the quarter.

Shares of HEMO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemogenyx Pharmaceuticals investors own include 4D pharma (DDDD), genedrive (GDR), International Consolidated Airlines Group (IAG), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP) and Coats Group (COA).

Company Calendar

Last Earnings
4/28/2025
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:HEMO
Previous Symbol
LON:SILF
CIK
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.89 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-80.66%
Return on Assets
-37.79%

Debt

Debt-to-Equity Ratio
90.87
Current Ratio
4.38
Quick Ratio
6.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 71.37 per share
Price / Cash Flow
2.05
Book Value
GBX 0.25 per share
Price / Book
592.45

Miscellaneous

Outstanding Shares
3,564,489
Free Float
N/A
Market Cap
£5.20 million
Optionable
Not Optionable
Beta
3.14
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (LON:HEMO) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners